ID

33084

Beschreibung

Study ID: 104020 Clinical Study ID: 104020 Study Title: Blinded, randomised study to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ live attenuated measles-mumps-rubella-varicella candidate vaccine when given to healthy children in their second year of life Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00126997 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Combined Measles, Mumps, Rubella, Varicella Vaccine Trade Name: Priorix Tetra Study Indication: Measles; Mumps; Rubella; Varicella

Stichworte

  1. 26.11.18 26.11.18 -
Rechteinhaber

GSK group of companies

Hochgeladen am

26. November 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Immunogenicity of Combined Measles, Mumps, Rubella, Varicella Vaccine for healthy 2 y.o children - 104020

Study Conclusion Form

  1. StudyEvent: ODM
    1. Study Conclusion Form
Administrative data
Beschreibung

Administrative data

Subject Number
Beschreibung

Subject Number

Datentyp

integer

Occurrence of Serious Adverse Event
Beschreibung

Occurrence of Serious Adverse Event

Did the subject experience any Serious Adverse Events during the study period?
Beschreibung

Did the subject experience any Serious Adverse Events during the study period?

Datentyp

boolean

If Yes, please specify total number of SAE's
Beschreibung

If Yes, please specify total number of SAE's

Datentyp

integer

Status of treatment blind
Beschreibung

Status of treatment blind

Was the treatment blind broken during this study?
Beschreibung

For the control group, please tick 'No'

Datentyp

boolean

If Yes, please complete date
Beschreibung

If Yes, please complete date

Datentyp

date

Check the reason of blind breach
Beschreibung

Check the reason of blind breach

Datentyp

integer

If Other, specify
Beschreibung

complete Non-Serious Adverse Event section or Serious Adverse Event form as appropriate

Datentyp

text

Elimination Criteria
Beschreibung

Elimination Criteria

Did any elimination criteria become applicable during the study?
Beschreibung

Did any elimination criteria become applicable during the study?

Datentyp

boolean

If Yes, specify
Beschreibung

If Yes, specify

Datentyp

text

Was the subject withdrawn from study?
Beschreibung

Was the subject withdrawn from study?

Datentyp

boolean

If Yes, please tick the ONE most appropriate category for withdrawal
Beschreibung

If Yes, please tick the ONE most appropriate category for withdrawal

Datentyp

text

If SAE, please specify SAE Number
Beschreibung

If SAE, please specify SAE Number

Datentyp

integer

If Non-SAE please specify unsolicited AE Number
Beschreibung

If Non-SAE please specify unsolicited AE Number

Datentyp

integer

If Protocol violation, please specify
Beschreibung

If Protocol violation, please specify

Datentyp

text

If Other, please specify
Beschreibung

If Other, please specify

Datentyp

text

Please tick who took decision
Beschreibung

Please tick who took decision

Datentyp

text

Date of last contact
Beschreibung

Date of last contact

Datentyp

date

Was the subject in good condition at date of last contact?
Beschreibung

Was the subject in good condition at date of last contact?

Datentyp

text

Investigator's Signature
Beschreibung

Investigator's Signature

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my collegues is, to the best of my knowledge, complete and accurate, as of the date below.
Beschreibung

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my collegues is, to the best of my knowledge, complete and accurate, as of the date below.

Datentyp

date

Investigator's signature
Beschreibung

Investigator's signature

Datentyp

text

Printed Investigator's name
Beschreibung

Printed Investigator's name

Datentyp

text

Ähnliche Modelle

Study Conclusion Form

  1. StudyEvent: ODM
    1. Study Conclusion Form
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Administrative data
Subject Number
Item
Subject Number
integer
Item Group
Occurrence of Serious Adverse Event
Did the subject experience any Serious Adverse Events during the study period?
Item
Did the subject experience any Serious Adverse Events during the study period?
boolean
If Yes, please specify total number of SAE's
Item
If Yes, please specify total number of SAE's
integer
Item Group
Status of treatment blind
Was the treatment blind broken during this study?
Item
Was the treatment blind broken during this study?
boolean
If Yes, please complete date
Item
If Yes, please complete date
date
Item
Check the reason of blind breach
integer
Code List
Check the reason of blind breach
CL Item
Medical emergency requiring identification of investigational product for further treatments (1)
CL Item
Other (2)
If Other, specify
Item
If Other, specify
text
Item Group
Elimination Criteria
Did any elimination criteria become applicable during the study?
Item
Did any elimination criteria become applicable during the study?
boolean
If Yes, specify
Item
If Yes, specify
text
Was the subject withdrawn from study?
Item
Was the subject withdrawn from study?
boolean
Item
If Yes, please tick the ONE most appropriate category for withdrawal
text
Code List
If Yes, please tick the ONE most appropriate category for withdrawal
CL Item
Serious adverse event (check SAE number) (1)
CL Item
Non-Serious adverse events (check the Non-SAE) (2)
CL Item
Protocol violation (3)
CL Item
Consent withdrawal, not due to an adverse event (4)
CL Item
Migrated/moved from the study area (5)
CL Item
Lost to follow-up (6)
CL Item
Other (7)
If SAE, please specify SAE Number
Item
If SAE, please specify SAE Number
integer
If Non-SAE please specify unsolicited AE Number
Item
If Non-SAE please specify unsolicited AE Number
integer
If Protocol violation, please specify
Item
If Protocol violation, please specify
text
If Other, please specify
Item
If Other, please specify
text
Item
Please tick who took decision
text
Code List
Please tick who took decision
CL Item
Investigator (1)
CL Item
Parents/Guardians (2)
Date of last contact
Item
Date of last contact
date
Item
Was the subject in good condition at date of last contact?
text
Code List
Was the subject in good condition at date of last contact?
CL Item
Yes (1)
CL Item
No, please give details within the Adverse Events section (2)
Item Group
Investigator's Signature
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my collegues is, to the best of my knowledge, complete and accurate, as of the date below.
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my collegues is, to the best of my knowledge, complete and accurate, as of the date below.
date
Investigator's signature
Item
Investigator's signature
text
Printed Investigator's name
Item
Printed Investigator's name
text

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video